Coronavirus to weigh on every aspect of Germany’s EU presidency

Euractiv | Apr 8, 2020 at 6:14 PM
  • The coronavirus crisis comes just as Germany was about to finalise its rotating EU presidency programme.
  • The draft also stressed that it is “essential” to strengthen the global competitiveness of the pharmaceutical sector and “ensure access to innovative medicines”.
  • German weekly Welt am Sonntag reported mid-March that President Donald Trump offered Tübingen-based biotech company CureVac around $1 billion to secure exclusive rights to a potential coronavirus vaccine.